JP2023520402A5 - - Google Patents

Info

Publication number
JP2023520402A5
JP2023520402A5 JP2022559589A JP2022559589A JP2023520402A5 JP 2023520402 A5 JP2023520402 A5 JP 2023520402A5 JP 2022559589 A JP2022559589 A JP 2022559589A JP 2022559589 A JP2022559589 A JP 2022559589A JP 2023520402 A5 JP2023520402 A5 JP 2023520402A5
Authority
JP
Japan
Prior art keywords
sequence
raav
item
promoter
enhancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022559589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520402A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024892 external-priority patent/WO2021202532A1/en
Publication of JP2023520402A publication Critical patent/JP2023520402A/ja
Publication of JP2023520402A5 publication Critical patent/JP2023520402A5/ja
Pending legal-status Critical Current

Links

JP2022559589A 2020-03-31 2021-03-30 プロピオン酸血症を処置するための遺伝子治療 Pending JP2023520402A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063002541P 2020-03-31 2020-03-31
US63/002,541 2020-03-31
PCT/US2021/024892 WO2021202532A1 (en) 2020-03-31 2021-03-30 Gene therapy for treating propionic acidemia

Publications (2)

Publication Number Publication Date
JP2023520402A JP2023520402A (ja) 2023-05-17
JP2023520402A5 true JP2023520402A5 (cg-RX-API-DMAC7.html) 2024-04-10

Family

ID=75660311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022559589A Pending JP2023520402A (ja) 2020-03-31 2021-03-30 プロピオン酸血症を処置するための遺伝子治療

Country Status (6)

Country Link
US (1) US12686874B2 (cg-RX-API-DMAC7.html)
EP (1) EP4127189A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023520402A (cg-RX-API-DMAC7.html)
AR (1) AR121709A1 (cg-RX-API-DMAC7.html)
TW (1) TW202204624A (cg-RX-API-DMAC7.html)
WO (1) WO2021202532A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019354296A1 (en) 2018-10-01 2021-04-29 Ultragenyx Pharmaceutical Inc. Gene therapy for treating propionic acidemia
US12686874B2 (en) 2020-03-31 2026-07-21 Ultragenyx Pharmaceutical Inc. Gene therapy for treating propionic acidemia
US20240175050A1 (en) * 2021-03-19 2024-05-30 Mayo Foundation For Medical Education And Research Methods and materials for treating propionic acidemia
US20250049952A1 (en) * 2021-12-29 2025-02-13 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Improved gene therapy constructs for the treatment of propionic acidemia caused by mutations in propionyl-coa carboxylase alpha

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018628B1 (en) 1998-07-24 2006-03-28 Aventis Pharma S.A. Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates
US6569662B1 (en) * 2000-01-21 2003-05-27 Hyseq, Inc. Nucleic acids and polypeptides
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
PL2657248T3 (pl) 2003-06-19 2017-09-29 Genzyme Corporation Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
DK2623605T3 (en) 2007-04-09 2019-03-25 Univ Florida RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
US9725485B2 (en) 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
US9611302B2 (en) 2007-04-09 2017-04-04 University Of Florida Research Foundation, Inc. High-transduction-efficiency RAAV vectors, compositions, and methods of use
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
ES2685611T3 (es) 2011-02-14 2018-10-10 The Children's Hospital Of Philadelphia Vector VAA8 mejorado con una actividad funcional aumentada y métodos de utilización del mismo
DK3693025T3 (da) 2011-04-22 2022-01-10 Univ California Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
JP6342886B2 (ja) 2012-04-18 2018-06-13 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
US10294281B2 (en) 2012-05-15 2019-05-21 University Of Florida Research Foundation, Incorporated High-transduction-efficiency rAAV vectors, compositions, and methods of use
US10266845B2 (en) 2013-02-08 2019-04-23 The Trustees Of The University Of Pennsylvania Enhanced AAV-mediated gene transfer for retinal therapies
US20140303901A1 (en) 2013-04-08 2014-10-09 Ilan Sadeh Method and system for predicting a disease
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
KR102272932B1 (ko) * 2013-10-25 2021-07-05 싸이오서스 테라퓨틱스 엘티디. 이종 유전자로 무장된 종양살상 아데노바이러스
KR20170044194A (ko) * 2014-08-27 2017-04-24 싸이오서스 테라퓨틱스 엘티디. 아데노바이러스의 제조를 위한 공정
WO2016049230A1 (en) 2014-09-24 2016-03-31 City Of Hope Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
US10081659B2 (en) 2015-04-06 2018-09-25 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Adeno-associated vectors for enhanced transduction and reduced immunogenicity
WO2016179138A1 (en) 2015-05-03 2016-11-10 The Regents Of The University Of Colorado Propionyl-coa carboxylase compositions and uses thereof
PL3298134T3 (pl) 2015-05-16 2023-09-18 Genzyme Corporation Edycja genów mutacji głęboko intronowych
US10143760B2 (en) 2015-10-28 2018-12-04 Sangamo Therapeutics, Inc. Liver-specific constructs, factor VIII expression cassettes and methods of use thereof
WO2017096164A1 (en) 2015-12-02 2017-06-08 The Board Of Trustees Of The Leland Stanford Junior University Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
CA3014637A1 (en) 2016-02-16 2017-08-24 Mark A. Kay Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
WO2017165859A1 (en) 2016-03-24 2017-09-28 Research Institute At Nationwide Children's Hospital Modified viral capsid proteins
WO2017173043A1 (en) 2016-03-30 2017-10-05 Spark Therapeutics, Inc. Cell line for recombinant protein and/or viral vector production
US11191847B2 (en) 2016-04-15 2021-12-07 The Trustees Of The University Of Pennsylvania Gene therapy for treating hemophilia B
CN109661470A (zh) 2016-04-15 2019-04-19 宾夕法尼亚州大学信托人 新型aav8突变衣壳和含有其的组合物
WO2017192761A1 (en) 2016-05-03 2017-11-09 The Regents Of The University Of Colorado, A Body Corporate Propionyl-coa carboxylase compositions and uses thereof
CN109640949B (zh) 2016-07-29 2022-11-25 加利福尼亚大学董事会 具有变异衣壳的腺相关病毒病毒体和其使用方法
EP3562494A4 (en) 2016-12-30 2020-08-19 The Trustees Of The University Of Pennsylvania GENE THERAPY FOR THE TREATMENT OF PHENYLKETONURIS
KR102863181B1 (ko) 2016-12-30 2025-09-23 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 윌슨병을 치료하기 위한 유전자 치료
WO2018144709A2 (en) 2017-02-01 2018-08-09 The Trustees Of The University Of Pennsylvania Gene therapy for treating citrullenemia
EP3585883A4 (en) 2017-02-21 2021-04-14 University of Florida Research Foundation, Incorporated MODIFIED AAV CAPSID PROTEINS AND USES THEREOF
WO2018222503A1 (en) 2017-05-31 2018-12-06 The Regents Of The University Of California Adeno-associated virus with variant capsid and methods of use thereof
WO2018226602A1 (en) 2017-06-05 2018-12-13 Research Institute At Nationwide Children's Hospital Enhanced modified viral capsid proteins
IL276859B2 (en) 2018-02-27 2025-12-01 Univ Pennsylvania Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor
AU2019354296A1 (en) 2018-10-01 2021-04-29 Ultragenyx Pharmaceutical Inc. Gene therapy for treating propionic acidemia
AU2021218703A1 (en) * 2020-02-14 2022-07-28 Ultragenyx Pharmaceutical Inc. Gene therapy for treating CDKL5 deficiency disorder
US12686874B2 (en) 2020-03-31 2026-07-21 Ultragenyx Pharmaceutical Inc. Gene therapy for treating propionic acidemia

Similar Documents

Publication Publication Date Title
JP2022516283A5 (cg-RX-API-DMAC7.html)
JP2023514204A5 (cg-RX-API-DMAC7.html)
JP2022500066A5 (cg-RX-API-DMAC7.html)
FI3906066T3 (fi) Geeniterapiakonstrukteja wilsonin taudin hoitamiseksi
JP2022513318A5 (cg-RX-API-DMAC7.html)
JP2024095717A5 (cg-RX-API-DMAC7.html)
JP2024054426A5 (cg-RX-API-DMAC7.html)
JP2021502060A5 (cg-RX-API-DMAC7.html)
JP2021522842A5 (cg-RX-API-DMAC7.html)
RU2015144234A (ru) Композиции и способы лечения mps1
JP2021513999A5 (cg-RX-API-DMAC7.html)
JP2016512683A5 (cg-RX-API-DMAC7.html)
IL299325B2 (en) Acid-alpha glucosidase variants and uses thereof
JP2024523707A5 (cg-RX-API-DMAC7.html)
JP2025515979A5 (cg-RX-API-DMAC7.html)
RU2019133002A (ru) ЭКСПРЕССИОННЫЕ КАССЕТЫ MeCP2
JP2022553083A5 (cg-RX-API-DMAC7.html)
JP2022505877A5 (cg-RX-API-DMAC7.html)
FI3850089T3 (fi) Polynukleotidejä
JP2022533448A5 (cg-RX-API-DMAC7.html)
RU2018145010A (ru) Оптимизированные гены и экспрессионные кассеты cln1, и их применение
JP2024545183A5 (cg-RX-API-DMAC7.html)
JP2021510301A5 (cg-RX-API-DMAC7.html)
JP2024532758A5 (cg-RX-API-DMAC7.html)
JP2024056832A5 (cg-RX-API-DMAC7.html)